Search

Stakeholders can use information generated from cost-benefit, co-benefit, and general economic analyses to make informed, evidence-based decisions for health.

A study co-authored by Abt’s Sebastian Lemire captured the state of the art of evaluation capacity building research, including 20 years of trends and findings.

Agreement between self-reported and medical record COVID-19 vaccination status means relying on self-reported data is a viable research method.

This study of an Opioid Quality Improvement Collaborative can help providers adopt CDC opioid guidelines and improve their prescribing practices.

Abt experts co-authored a study explaining how stakeholders—including individual citizens—can better estimate PFAS blood levels from water concentrations.

A new study shows that low influenza infection rates for pregnant women during the COVID-19 pandemic were consistent with data for the general population.

This report reviews the efforts of Massachusetts and Minnesota to blend their MCOs with an ACO approach to meet Medicaid’s goals.

As a provider of technical assistance (TA), Abt recognizes that the measure of our success ultimately is the ability of TA recipients to operate on their own.

Abt conducts technical analyses and supports community engagement to help agencies identify and address the impacts of environmental justice actions.

Abt has extensive experience investigating and addressing the complex effects of per- and polyfluoroalkyl substances (PFAS) in the environment and on human health.